Medibio Ltd News

Medibio Ltd: Notice of AGM and Closing Date for Director Nominations

Oct 5, 2023 19:25 ET

Medibio Ltd: Appendix 4G

Sep 28, 2023 19:29 ET

Medibio Ltd: Corporate Governance Statement

Sep 28, 2023 19:26 ET

Medibio Ltd: Phase 2 Trial Commences for SAMDE Study

Sep 3, 2023 18:30 ET

Medibio Ltd: Trading Halt

Aug 2, 2023 18:38 ET

Medibio Ltd: June 2023 Quarterly Activities Report and Appendix 4C

Jul 30, 2023 18:25 ET

Medibio Ltd: Phase 1 Trial Completed for SAMDE Study

Jul 23, 2023 18:21 ET

Medibio Ltd: Update on Breakthrough Device Designation with US FDA

Jul 20, 2023 18:20 ET

Medibio Ltd: Change of Director's Interest Notice - David Trimboli

Jun 21, 2023 19:38 ET

Medibio Ltd: Change of Director's Interest Notice - Chris Ntoumenopoulos

Jun 21, 2023 19:37 ET

Medibio Ltd: Change in Venue and Time for Extraordinary General Meeting

May 1, 2023 03:06 ET

Medibio Ltd: March 2023 Quarterly Activities Report and Appendix 4C

Apr 26, 2023 18:15 ET

Medibio Ltd: MEB Executes Bridging Loans with Directors

Apr 21, 2023 00:27 ET

Medibio Ltd: Initial Director's Interest Notice - Thomas Young

Apr 16, 2023 19:40 ET

Medibio Ltd: Final Director's Interest Notice

Apr 12, 2023 03:16 ET

Medibio Ltd: Appendix 3Z

Mar 16, 2023 01:25 ET

Medibio Ltd: Medibio Lodges Breakthrough Device Designation with FDA

Feb 26, 2023 17:52 ET

Medibio Ltd: Appendix 3X

Feb 16, 2023 18:44 ET

Medibio Ltd: Medibio Appoints Non-Executive Director to the Board

Feb 14, 2023 17:07 ET

Medibio Ltd: Trading Halt

Feb 10, 2023 01:28 ET